Skip to main content

Published locations for AVERT: Apixaban reduced thromboembolism risk in cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. AVERT: Apixaban reduced thromboembolism risk in cancer patients

User login

  • Reset your password
  • /content/avert-apixaban-reduced-thromboembolism-risk-cancer-patients
  • /familypracticenews/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /hematologynews/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer-patients
  • /internalmedicinenews/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /oncologypractice/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /anticoagulationhub/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /hematology-oncology/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /ecardiologynews/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /cardiology/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer-patients
  • /internalmedicine/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer
  • /familymedicine/article/190209/thrombosis/avert-apixaban-reduced-thromboembolism-risk-cancer-patients